The Impact of Smoking on Outcomes and Complications in Total Joint Arthroplasty: A Prospective Crossover Study
1 other identifier
observational
1,200
1 country
1
Brief Summary
The purpose of this study is to examine the impact of smoking cessation on total joint arthroplasty patients with respect to perioperative complications and outcomes. The investigators will examine patients who are asked to stop smoking in any manner they choose and also refrain from nicotine replacement therapy, and those who are allowed to continue smoking during the perioperative period for their total knee or total hip replacement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 13, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedOctober 19, 2020
October 1, 2020
4.7 years
October 13, 2020
October 16, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Wound healing
The primary objective of this study is to examine the impact of smoking cessation on total joint arthroplasty patients with respect to combined complications. For the purpose of the study combined complications will include: major in-hospital complications (MI, CVA, PE, pneumonia, return to the operating room, mortality), wound complications, readmission at 90 days, 90-day major complications (MI, CVA, PE, pneumonia, return to the operating room, mortality), and wound complications (prolonged hospitalization due to a wound issue, prolonged drainage \> 7 days, superficial or deep SSI
3 months
Study Arms (2)
Smoking Cessation Group
participants are required to cease smoking for 4 weeks prior to and 2 weeks after TJA without any nicotine replacement (any other smoking cessation aids the patient chooses will be allowed)
Smoker Group 2
participants who are allowed to continue smoking and using nicotine in any form at their own discretion during the perioperative period
Interventions
2-4 weeks before surgery a blood draw will be taken to test for nicotine levels in the body
Eligibility Criteria
Patients who are current smokers having surgery for total joint arthroplasty at Rothman Orthopaedic Institute
You may qualify if:
- Primary elective total joint arthroplasty patients undergoing surgery with a Rothman Institute arthroplasty surgeon.
- Participant is a current smoker.
- Diagnosis of osteoarthritis, inflammatory arthritis, and post-traumatic arthritis.
- Age \< 18
- Revision surgery
- Prior infection in hip or knee at the surgical site
- BMI \>40 (It is currently the standard of care in our practice to require patients to have a BMI \< 40 due to an increased risk of infection. This will not represent a change in practice.)
- Diabetics with Hgb A1C \>8 (It is currently the standard of care in our practice to require patients to have a Hgb A1C \<8 due to an increased risk of infection. This will not represent a change in practice.)
- Patients using chewing tobacco, cigars, or other form of oral tobacco product
- Patients using e-cigarettes or vaporizers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2020
First Posted
October 19, 2020
Study Start
December 1, 2016
Primary Completion
July 31, 2021
Study Completion
July 31, 2021
Last Updated
October 19, 2020
Record last verified: 2020-10